Allotment of Securities

June 24, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir / Madam, Sub: Allotment of 22,062 Equity Shares pursuant to Aarti Pharma Performance Stock Option Plan 2023 (“PSOP 2023”) Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This to inform that, the Nomination and Remuneration Committee of the Board of Directors of the Company through a resolution by circulation have allotted 22,062 equity shares of face value of Rs. 5/- each pursuant to exercise of stock options held by eligible employees of the Company under Aarti Pharma Performance Stock Option Plan 2023 (PSOP 2023) and subject to the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The said Equity Shares shall rank pari-passu in all respect with the existing Equity Shares of the Company Post this allotment, the paid-up Equity share capital of the Company stands increased to Rs. 45,33,99,065 (Rs. Forty-five crore thirty-three lakhs ninety-nine thousand and sixty-five Only) representing 9,06,79,813 (Nine crore, six lakhs, seventy-nine thousand eight hundred and thirteen Only) fully paid-up equity shares of face value of Rs.5/- each. Please take the same on your records. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565